Funding

Opsin secures $21M to secure enterprise AI agents, led by SYN Ventures and Race Capital

Share
Opsin secures $21M to secure enterprise AI agents, led by SYN Ventures and Race Capital

Opsin, a San Jose-based cybersecurity startup, has raised $21 million in financing led by SYN Ventures and Race Capital. The funding will support the development of its security and governance software for autonomous enterprise AI agents.

TL;DR

  • Opsin raises $21 million to secure enterprise AI agents, with SYN Ventures and Race Capital leading the round.
  • Sirona Medical secures $40 million Series D for its cloud-native radiology platform, RadOS.
  • Shamrock AI raises $5 million seed funding for its enterprise AI agent assurance platform.

What happened

Opsin, founded by James Pham, Oz Wasserman, and Jeremy Mailen, announced a $21 million financing round on October 15. The round was led by SYN Ventures and Race Capital. The company develops security and governance software for autonomous enterprise AI agents, helping security teams detect unauthorized access and unusual actions. The funding will support engineering recruitment, product development, and sales expansion. Opsin did not disclose its valuation or funding stage.

Sirona Medical, a San Francisco-based healthcare software company, secured $40 million in Series D financing on October 15. The round was led by Avidity Partners, with participation from 8VC, GreatPoint Ventures, KLT Holdings, and other existing shareholders. Sirona develops RadOS, a cloud-native radiology operating platform that integrates various diagnostic and AI-assisted clinical workflows. The company reported significant growth in platform usage, annual recurring revenue, and contracted annual recurring revenue. The financing will support product development, customer deployment, and operational expansion. Sirona did not disclose its latest valuation.

Shamrock AI, an Indian enterprise AI startup, raised $5 million in seed financing led by Endiya Partners, with participation from Capria Ventures. Founded in 2026 by Sarat Addanki, Michael Gallagher, and Anuraag Nallapati, the company is headquartered in Shillong, Meghalaya, with operations in Hyderabad and San Francisco. Shamrock develops an AI assurance platform that tests and validates autonomous enterprise agents. The company reports working with several Fortune 500 enterprises. The funding will support engineering, product development, and expansion across India, the United States, and the Middle East.

Why it matters

For developers and startups, Opsin's funding highlights the growing need for security and governance solutions in the rapidly expanding field of autonomous AI agents. This could open up new opportunities for collaboration and innovation in enterprise AI security.

Sirona Medical's significant Series D funding underscores the increasing importance of cloud-native radiology platforms and AI-assisted clinical workflows in the healthcare industry. This could drive further advancements in medical imaging and diagnostic technologies, benefiting both healthcare providers and patients.

Shamrock AI's seed funding reflects the rising demand for AI assurance platforms that can validate and test autonomous enterprise agents. This development could encourage more startups to explore similar solutions, addressing critical business system dependencies and workflows.

Key facts

  • Opsin raised $21 million in financing led by SYN Ventures and Race Capital on October 15.
  • Sirona Medical secured $40 million in Series D financing led by Avidity Partners on October 15.
  • Shamrock AI raised $5 million in seed financing led by Endiya Partners, with participation from Capria Ventures.
  • Opsin's platform monitors AI agent behavior and identifies policy violations.
  • Sirona Medical's RadOS integrates picture archiving, diagnostic image viewing, and AI-assisted clinical workflows.
  • Shamrock AI's platform uses an Enterprise Business Knowledge Graph to understand workflows and business rules.
  • Sirona Medical reported a more than 2.5 times year-over-year increase in platform usage, annual recurring revenue, and contracted annual recurring revenue.
  • Shamrock AI is headquartered in Shillong, Meghalaya, with operations in Hyderabad and San Francisco.

Context

The recent funding rounds for Opsin, Sirona Medical, and Shamrock AI highlight the growing investment in AI-driven solutions across various industries. As enterprises increasingly adopt autonomous AI agents, the need for security, governance, and assurance platforms becomes more critical. These developments reflect a broader trend in the AI landscape, where startups are focusing on addressing the unique challenges posed by AI integration in business systems.

Topics

Join the discussion

Have a take on this story? Weigh in with our community on Facebook.

💬 Discuss on Facebook →